🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess whether switching nAMD patients from...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-05-31
Trial ID
NCT04697953
Treatments Being Tested
This was a 64-week randomized, double-masked, multi-center, active-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-25
Trial ID
NCT04005352
Treatments Being Tested
This study is a 60-week, two-arm, randomized, open-label, active-controlled...
Status
Completed
Location
Novartis Investigative Site
Start Date
2023-02-06
Trial ID
NCT05666804
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy of brolucizumab...
Status
Active Not Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-07-10
Trial ID
NCT06498050
Treatments Being Tested
Neovascular age-related macular degeneration (nAMD) is characterized by the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-01-26
Trial ID
NCT04239027
Treatments Being Tested
To compare brolucizumab to aflibercept in Chinese patients with untreated a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-11-29
Trial ID
NCT04047472
Treatments Being Tested
This study was a prospective, uncontrolled, central registration system, mu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-11-16
Trial ID
NCT04632056
Treatments Being Tested
Neovascular age-related macular degeneration is characterized by the presen...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-14
Trial ID
NCT04264819
Treatments Being Tested
PNV is a recently described clinical entity; therefore, studies about treat...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05672979
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-07-17
Trial ID
NCT03917472
Treatments Being Tested